Amgen (AMGN) Announces Breakthrough Therapy Designation Granted For Sotorasib In China
Go back to Amgen (AMGN) Announces Breakthrough Therapy Designation Granted For Sotorasib In ChinaAmgen Inc (NASDAQ: AMGN) | Delayed: 286.30 +4.53 (1.61%) | |||||
---|---|---|---|---|---|---|
Previous Close | $281.77 | 52 Week High | $176.85 | |||
Open | $284.22 | 52 Week Low | $133.64 | |||
Day High | $286.82 | P/E | 43.12 | |||
Day Low | $282.55 | EPS | $6.64 | |||
Volume | 2,256,153 |